Chinese Traditional and Herbal Drugs
|
2025, 56(16): 5782-5791
Optimization of forming process and pharmacodynamic investigation of Hulisan gel plaster
Full
MEI Jiahua, ZHA Xuezhi, ZHANG Hailiang, ZHANG Quan, ZHANG Zhanyao, WANG Yongseng, LI Yichan, MA Yunshu
Affiliations
About Author:
云南省科技厅社会发展专项—重点研发计划项目 (202303AC100025); 国家中医药管理局“十二五”重点学科—傣药学; 国家自然科学基金资助项目 (82174065); 云南省教育厅科学研究基金项目 (2024Y379); 云南省中西医结合慢病防治重点实验室开放基金资助项目 (YPKLG2024-016); 云南省傣医药与彝医药重点实验室资助项目 (2024SS24074)
doi: 10.7501/j.issn.0253-2670.2025.16.008
Outline
Objective To optimise the forming process of Hulisan gel plaster (HLS-GP, 虎力散凝胶贴膏) and conduct preliminary pharmacodynamic investigation. Methods Orthogonal test was used to optimise the forming process of HLS-GP with initial tack, holding power, adhesion and sensory score as indicators. Lobetyolin, notoginsenoside R1 (NR1), 8-deacetyl-yunaconitine (8D-YNA), yunaconitine and ginsenoside Rg1 (GRg1) were used as indicators to investigate the in vitro release and transdermal permeability of HLS-GP and to screen for the optimal osmotic enhancer from azone, propylene glycol and menthol. A preliminary investigation of the anti-inflammatory and analgesic effects of HLS-GP through ear swelling and acetic acid writhing modelling. Results The optimum formulation of HLS-GP was 11 g NP700, 0.8 g aluminium glycinate, 1.5 g kaolin, 40 g glycerol, 0.8 g tartaric acid, 6 g PVP K90 and 20 g water, which confirmed that the results of the experiment met the requirements. The established methods for the determination of 8D-YNA, yunaconitine, lobetyolin, NR1 and GRg1 contents were applicable. And the 24 h cumulative release rates were (65.93 ±0.10)%, (77.42 ±0.13)%, (80.08 ±0.87)%, (69.86 ±0.17)% and (21.90 ±0.68)%, respectively, and the release behaviour followed the first-order kinetic equation. The optimal osmotic enhancer obtained from the screening was 5% propylene glycol, and the cumulative osmolality of the five components at 24 h were (136.16 ±0.07), (319.50 ±0.05), (16.92 ±0.05), (10.27 ±0.06) and (166.69 ±0.08) μg/cm2, respectively. The anti-inflammatory and analgesic results showed that, compared with the control group, mice in the model group had obvious ear swelling, short latency, and a high number of writhing, whereas HLS-GP was able to significantly inhibit ear swelling, prolong latency, and reduce the number of writhing in the mice (P < 0.05). At the same time, HLS-GP was able to significantly reduce the serum levels of the inflammatory factors interleukin-6 (IL-6), IL-1β and tumor necrosis factor-α (TNF-α) in the mice with ear swelling and significantly reduce the serum levels of 5-hydroxytryptamine (5-HT), IL-1β and prostaglandin E2 (PGE2) in the acetate writhing mice (P < 0.05, 0.01). Conclusion HLS-GP with good in vitro drug release and transdermal permeability and good anti-inflammatory and analgesic effects were obtained, which can lay the foundation for the development of transdermal drug delivery formulations of Hulisan.
Hulisan
/
gel plaster
/
in vitro evaluation
/
permeation enhancer
/
anti-inflammatory and analgesic
/
lobetyolin
/
notoginsenoside R1
/
8-deacetyl-yunaconitine
/
yunaconitine
/
ginsenoside Rg1
梅佳华, 查学志, 张海亮, 张权, 张占尧, 王勇森, 李一婵, 马云淑.
虎力散凝胶贴膏的成型工艺优化及药效学考察.
中草药,
2025
, 56
(16)
: 5782
-5791
.
DOI: 10.7501/j.issn.0253-2670.2025.16.008
MEI Jiahua, ZHA Xuezhi, ZHANG Hailiang, ZHANG Quan, ZHANG Zhanyao, WANG Yongseng, LI Yichan, MA Yunshu.
Optimization of forming process and pharmacodynamic investigation of Hulisan gel plaster[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(16)
: 5782
-5791
.
DOI: 10.7501/j.issn.0253-2670.2025.16.008
Year 2025 volume 56 Issue 16
44
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.16.008
- Receive Date:2025-02-25
- Online Date:2026-11-12